Latest Growth Opportunities News

Eminence Minerals has sold its non-core Mata da Corda Project in Brazil for USD 2 million, boosting its cash reserves and sharpening focus on priority assets.

Talga Group has begun commercial deliveries of its Talnode®-C battery anode to Nyobolt, marking a key revenue milestone and advancing its European supply ambitions. The 3,000-tonne offtake deal sets the stage for Talga's planned commercial-scale anode plant, with further customer negotiations underway.

Navigator Global Investments has finalised its US$190 million acquisition of a diversified portfolio from Stable Asset Management, establishing a strategic partnership to manage the new assets and expanding its alternative investment footprint.

BCAL Diagnostics has acquired a 10.2% stake in Genetic Signatures for $1.39 million, aiming to merge early cancer detection with infectious disease diagnostics and expand its international footprint.

True North Copper (ASX:TNC) has confirmed a new high-grade copper-gold structure at its Wallace North deposit in Queensland, with drill results highlighting significant resource growth potential.

ACDC Metals has locked in a crucial 10-year Retention Licence for its Goschen Central rare earth and heavy mineral sands project, underpinning long-term development plans backed by a robust $384 million NPV8 Scoping Study.

Echo IQ has raised approximately A$110 million through a heavily supported institutional placement to fund its US commercial rollout and speed up development of its AI-driven cardiovascular diagnostics.

Cobre Limited is progressing a major upgrade of its Sierra Atacama copper project in Chile, aiming to convert a large foreign resource estimate into a JORC-compliant Mineral Resource Estimate while launching a 40,000-metre drilling program targeting near-mine expansion and deeper sulphide mineralisation.

Tesoro Gold has accelerated its Definitive Feasibility Study and development readiness for the 1.82Moz Ternera deposit, forming strategic alliances and advancing financing plans.

Brookside Energy has wrapped up its latest on-market share buy-back, cutting its share count by 7% post-consolidation and funding the program entirely from operating cash flow. The company will pause buy-back activity as it finalises a proposed U.S. ADS listing but signals future buy-backs remain part of its capital strategy.

Bravura Solutions plans to list on the London Stock Exchange's AIM market by late July 2026, aiming to tap into UK and European institutional investors while maintaining its ASX primary listing.

Aroa Biosurgery delivered a breakout FY26 with NZ$104 million revenue, driven by strong Myriad sales and clinical trial success, setting the stage for ambitious FY27 growth.